Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction

Background-Insulin-like growth factor-1 (IGF-1) is recognized as an important regulator of cardiac structure and cardiomyocyte homeostasis. The prosurvival and antiapoptotic effects of IGF-1 have been investigated in vitro and in rodent models of myocardial infarction (MI). However, the clinical app...

Full description

Bibliographic Details
Main Authors: O'Sullivan, J., Leblond, A., Kelly, G., Kumar, A., Metharom, Pat, Büneker, C., Alizadeh-Vikali, N., Hristova, I., Hynes, B., O'Connor, R., Caplice, N.
Format: Journal Article
Published: 2011
Online Access:http://hdl.handle.net/20.500.11937/30558
_version_ 1848753122773565440
author O'Sullivan, J.
Leblond, A.
Kelly, G.
Kumar, A.
Metharom, Pat
Büneker, C.
Alizadeh-Vikali, N.
Hristova, I.
Hynes, B.
O'Connor, R.
Caplice, N.
author_facet O'Sullivan, J.
Leblond, A.
Kelly, G.
Kumar, A.
Metharom, Pat
Büneker, C.
Alizadeh-Vikali, N.
Hristova, I.
Hynes, B.
O'Connor, R.
Caplice, N.
author_sort O'Sullivan, J.
building Curtin Institutional Repository
collection Online Access
description Background-Insulin-like growth factor-1 (IGF-1) is recognized as an important regulator of cardiac structure and cardiomyocyte homeostasis. The prosurvival and antiapoptotic effects of IGF-1 have been investigated in vitro and in rodent models of myocardial infarction (MI). However, the clinical application of IGF-1 has been hampered by dose-dependent side effects both acutely and during chronic administration. We hypothesized that single, low-dose IGF-1 (LD-IGF-1) administered locally and early in the reperfusion phase after acute MI in a large animal model would avoid significant side effects but would have prosurvival effects that would manifest in long-term structural and functional improvement after MI treatment. Methods and Results-Forty-four female Landrace pigs underwent intracoronary administration of LD-IGF-1 or saline 2 hours into the reperfusion phase of acute left anterior descending artery occlusion MI. In the area of infarction, IGF-1 receptor and signaling responses were activated at 30 minutes and cardiomyocyte cell death attenuated at 24 hours after LD-IGF-1 but not saline treatment. Hemodynamic and structural studies using pressure-volume loop, CT, and triphenyltetrazolium chloride analysis 2 months post-MI confirmed a marked reduction in infarct size, attenuation of wall thinning, and augmentation of wall motion in the LD-IGF-1-treated but not in the saline-treated animals. These regional structural benefits were associated with global reductions in left ventricular volumes and significant improvement in left ventricular systolic and diastolic function. Conclusions-One-time LD-IGF-1 effects potent acute myocardial salvage in a preclinical model of left anterior descending artery occlusive MI, extending to long-term benefits in MI size, wall structure, and function and underscoring its potential as an adjunctive therapeutic agent. © 2011 American Heart Association, Inc.
first_indexed 2025-11-14T08:19:30Z
format Journal Article
id curtin-20.500.11937-30558
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:19:30Z
publishDate 2011
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-305582017-09-13T15:32:48Z Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction O'Sullivan, J. Leblond, A. Kelly, G. Kumar, A. Metharom, Pat Büneker, C. Alizadeh-Vikali, N. Hristova, I. Hynes, B. O'Connor, R. Caplice, N. Background-Insulin-like growth factor-1 (IGF-1) is recognized as an important regulator of cardiac structure and cardiomyocyte homeostasis. The prosurvival and antiapoptotic effects of IGF-1 have been investigated in vitro and in rodent models of myocardial infarction (MI). However, the clinical application of IGF-1 has been hampered by dose-dependent side effects both acutely and during chronic administration. We hypothesized that single, low-dose IGF-1 (LD-IGF-1) administered locally and early in the reperfusion phase after acute MI in a large animal model would avoid significant side effects but would have prosurvival effects that would manifest in long-term structural and functional improvement after MI treatment. Methods and Results-Forty-four female Landrace pigs underwent intracoronary administration of LD-IGF-1 or saline 2 hours into the reperfusion phase of acute left anterior descending artery occlusion MI. In the area of infarction, IGF-1 receptor and signaling responses were activated at 30 minutes and cardiomyocyte cell death attenuated at 24 hours after LD-IGF-1 but not saline treatment. Hemodynamic and structural studies using pressure-volume loop, CT, and triphenyltetrazolium chloride analysis 2 months post-MI confirmed a marked reduction in infarct size, attenuation of wall thinning, and augmentation of wall motion in the LD-IGF-1-treated but not in the saline-treated animals. These regional structural benefits were associated with global reductions in left ventricular volumes and significant improvement in left ventricular systolic and diastolic function. Conclusions-One-time LD-IGF-1 effects potent acute myocardial salvage in a preclinical model of left anterior descending artery occlusive MI, extending to long-term benefits in MI size, wall structure, and function and underscoring its potential as an adjunctive therapeutic agent. © 2011 American Heart Association, Inc. 2011 Journal Article http://hdl.handle.net/20.500.11937/30558 10.1161/CIRCINTERVENTIONS.110.960765 unknown
spellingShingle O'Sullivan, J.
Leblond, A.
Kelly, G.
Kumar, A.
Metharom, Pat
Büneker, C.
Alizadeh-Vikali, N.
Hristova, I.
Hynes, B.
O'Connor, R.
Caplice, N.
Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction
title Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction
title_full Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction
title_fullStr Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction
title_full_unstemmed Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction
title_short Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction
title_sort potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction
url http://hdl.handle.net/20.500.11937/30558